-
Presenters: James Greenblatt, MD & Daniel Dowd, PharmD
- Dates: August 7, 2023
- Format: 1 hr webinar recording
-
Registration: Free
Deficiency of the essential nutrient folate (Vitamin B9) is well-established as a risk factor for a range of neuropsychiatric conditions and low folate levels are consistently correlated with psychiatric symptom severity. In addition to diet, folate status is powerfully moderated by the MTHFR enzyme, as well as the gene that codes for it. MTHFR mutations can substantially impair folate metabolism and influence individual requirements for folate repletion and maintenance.
In this webinar, Dr. Greenblatt will present evidence-based strategies for MTHFR gene testing and blood folate testing to inform targeted protocols for folate augmentation and/or repletion.
Dr. Daniel Dowd, Genomind’s Senior Vice President of Medical Affairs, will also join us for this webinar, to talk about how you can incorporate their precision medicine tools into your practice.
This webinar is sponsored by Genomind, whose mission is to optimize the treatment experience for individuals and healthcare providers by unlocking the value of precision medicine through actionable genetic insights and innovative health technology. Learn more about Genomind below!
Our mission is to optimize the treatment experience for individuals and healthcare providers by unlocking the value of precision medicine through actionable genetic insights and innovative health technology.
Every year millions of people struggle through trial-and-error treatment or encounter preventable health complications due to adverse drug events. Annually, the societal costs to the healthcare industry are over $358 billion. Until recently, the information to help reduce guesswork, identify adverse drug events, and make personalized treatment decisions was lacking.
There is no one-size-fits all treatment, and Genomind’s platform was developed to unlock the potential of truly personalized medicine. With our comprehensive precision health platform, healthcare providers can quickly assess drug-drug, gene-drug, and drug-drug-gene interactions to deliver safer and more targeted approaches to treatment.
While our heritage is rooted in mental health PGx testing, we have grown to include a broader scope of conditions. Keeping a keen focus on the customer experience and maintaining a deep understanding of challenges faced in our health system, we create innovative solutions that make a meaningful difference in the lives of millions. Together, we can reduce costs, improve quality of care and increase patient and healthcare provider satisfaction.
That’s the science behind better.
Let’s redefine mental wellness together.
Sign-up now for the latest in functional news and research, course launches, exclusive offers and more.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.
